A federal court injunction has blocked the company's planned acquisition of JenaValve, forcing an immediate and significant change to its strategic growth plans. This disruption creates a need to find alternative ways to achieve the market expansion or technology acquisition goals the deal was intended to deliver.
Filing excerpt
On January 9, 2026 Edwards Lifesciences Corporation (the “Company”) issued a press release announcing that the United States District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission for an injunction blocking the Company’s proposed acquisition of JenaValve Technology, Inc (“JenaValve”).
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
Regions named
Competitors named
sec-8krestructuringGet every 8-K signal for Edwards Lifesciences and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Edwards Lifesciences this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/b78fbff9-f71a-4936-a0f7-f229002498fb returns this record as JSON. POST /v1/companies/enrich returns every signal for edwards.com.
{
"signal_id": "b78fbff9-f71a-4936-a0f7-f229002498fb",
"signal_type": "sec-8k",
"signal_subtype": "restructuring",
"detected_at": "2026-02-03T13:13:02.096+00:00",
"company": {
"name": "Edwards Lifesciences",
"domain": "edwards.com"
},
"data": {
"detail": "A federal court injunction has blocked the company's planned acquisition of JenaValve, forcing an immediate and significant change to its strategic growth plans. This disruption creates a need to find alternative ways to achieve the market expansion or technology acquisition goals the deal was intended to deliver.",
"metrics": {
"timeframe": "immediate"
},
"summary": "Edwards Lifesciences' acquisition of JenaValve Technology blocked by FTC injunction on Jan 9, 2026",
"excerpts": "On January 9, 2026 Edwards Lifesciences Corporation (the “Company”) issued a press release announcing that the United States District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission for an injunction blocking the Company’s proposed acquisition of JenaValve Technology, Inc (“JenaValve”).",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1099800/000109980026000002/ew-20260109.htm",
"filing_date": "2026-01-09",
"filing_year": 2026,
"sales_relevance": "Change management needs",
"signal_category": "workforce",
"regions_mentioned": [
"United States"
],
"competitors_mentioned": [
"JenaValve Technology, Inc"
]
}
}
curl https://signals.autobound.ai/v1/signals/b78fbff9-f71a-4936-a0f7-f229002498fb \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"edwards.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.